Ciprofloxacin Dosage and Administration Guidelines

Pediatric Dosing

For children, the American Academy of Pediatrics recommends a dosage of 10-15 mg/kg every 12 hours, not to exceed 1 g per day 1, 2
For neonates, the American Academy of Pediatrics recommends a dosage of 15 mg/kg twice daily 3, 4

Oral ciprofloxacin is rapidly and well absorbed with no substantial loss by first-pass metabolism, according to the American Family Physician 1, 2
Maximum serum concentrations are attained 1-2 hours after oral dosing, as reported by the American Family Physician 1, 2
For severe infections with poor clinical response, therapeutic drug monitoring may be considered, as suggested by Thorax 3, 4
Target serum levels for 500 mg twice daily are trough level 1 mg/L, peak level 3 mg/L, and for 750 mg twice daily are trough level 1.5 mg/L, peak level 4.5 mg/L, as recommended by Thorax 3, 4

ECG monitoring is recommended at baseline, 2 weeks, and after addition of any new medication known to prolong QT interval, as advised by Thorax 3, 4
Blood glucose monitoring is recommended in diabetic patients due to risk of hypoglycemia, as suggested by Thorax 3, 4
Routine toxicity monitoring (FBC, U&Es, LFTs) should be performed intermittently throughout treatment, as recommended by Thorax 3, 4

Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, and dyspepsia, as reported by Thorax 3, 4
Dermatological adverse effects include rash, photosensitivity, Stevens-Johnson syndrome, and toxic epidermal necrolysis, as reported by Thorax 3, 4
Administration site reactions may occur with IV formulation, as reported by Thorax 3, 4
Serious adverse effects include cardiovascular events such as QTc prolongation, as reported by Thorax 3, 4

The American Academy of Family Physicians recommends using ciprofloxacin only for FDA-approved indications in pediatric patients, such as inhalational anthrax and complicated urinary tract infections, due to the risk of permanent cartilage lesions in weight-bearing joints 5, 6, 7
The American Academy of Pediatrics advises avoiding ciprofloxacin in children under 18 years when alternative antibiotics exist, although it can be used with careful monitoring when necessary 6, 7

The American College of Obstetricians and Gynecologists recommends using ciprofloxacin during pregnancy only for life-threatening infections where benefits outweigh risks, such as inhalational anthrax 5
The American Academy of Family Physicians suggests avoiding fluoroquinolones during pregnancy and using alternative antibiotics like ampicillin, cefotaxime, or ceftriaxone for infections like Salmonella 7

The New England Journal of Medicine reports that gastrointestinal adverse effects, such as nausea, vomiting, diarrhea, and abdominal pain, are the most common reason for discontinuation of ciprofloxacin 6

Ciprofloxacin should be avoided in patients < 18 years of age, in pregnant women, and in breastfeeding mothers except when treating life‑threatening infections for which no acceptable alternative exists, because of the risk of cartilage damage in developing joints. (CDC MMWR Recommendations) 8, 9, 10

When ciprofloxacin is used in children because no alternative is available, reversible arthralgia occurs in approximately 3 % of patients, while radiographic evidence of permanent cartilage damage has not been demonstrated. (CDC MMWR Recommendations) 8

Concurrent administration of antimotility agents such as loperamide or diphenoxylate with ciprofloxacin for infectious diarrhea—particularly when Shiga‑toxin‑producing E. coli is a possible pathogen—should be avoided because it markedly increases the risk of hemolytic‑uremic syndrome. (Clinical Infectious Diseases) 11